The thesis

STERIS plc operates in the Healthcare sector with a revenue growth of 7.3% YoY and gross margin of 44.43%. The company's high net margin of 13.33% and P/E of 25.3x indicate strong profitability. The conviction score of 16/100 places it on the WATCHLIST, suggesting a nuanced setup. Analyst consensus rating is BUY, indicating potential for further growth.

Why now

The current macro context of tightening monetary policy may impact consumer discretionary spending, but Healthcare demand remains resilient. STERIS plc's revenue growth and high margins make it an attractive watch given its 7.3% YoY revenue growth.

What to watch

Future revenue growth and margin stability will be key indicators of the company's performance over the next 1-3 quarters. The company's ability to maintain its high margins despite potential economic tightening will be crucial to confirming the thesis.

Key risks

Valuation risk is present given the P/E of 25.3x, which may be sensitive to changes in interest rates. Execution risk is also a factor as the company needs to maintain its high margins and revenue growth.

Theme exposure